<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230301057585N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-03-10</date_registration>
      <primary_sponsor>Gonabad University of Medical Sciences</primary_sponsor>
      <public_title>Comparison of the effect of aromatherapy with lavender and clove essential oil on labor pain and anxiety</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the effect of lavender and clove essential oil on the intensity of pain and anxiety of the first stage of labor</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-04-04</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>159</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/68987</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Used, Assignment: Parallel, Purpose: Supportive, Randomization description: The samples of this study are selected using an easy and accessible sampling method And to allocate the samples to the studied groups, the block random allocation method will be used.For this purpose, the "blockran" package was used in R statistical software.In the relevant function in this package, the number of treatments was 3 and the volume of the block was 6, and then the studied samples were assigned to groups using the random sequence generated by the random blocks of 6, Blinding description: In this study, the participants are aware of the intervention, but they do not know the type of essential oil they are prescribed (lavender, clove or distilled water).</study_design>
      <phase>3</phase>
      <hc_freetext>pain and anxiety of the first stage of labor.</hc_freetext>
      <i_freetext>Intervention 1: First Intervention group: Aromatherapy with lavender essential oil with a concentration of 2% was purchased from Barich Essential Oil Company, which is impregnated with gas to the extent of 0.2 cc and attached to the collar of the participants' clothes, and its prescription is repeated every 15 minutes, and they are asked to breathe normally. Intervention 2: Second Intervention group: Aromatherapy with clove essential oil with a concentration of 2% was purchased from Barich Essential Oil Company, which is impregnated with gas to the extent of 0.2 cc and attached to the collar of the participants' clothes, and its prescription is repeated every 15 minutes, and they are asked to breathe normally. Intervention 3: Control group: In the control group, 0.2 cc of distilled water is impregnated with gas and attached to the collar of the participants' clothes, and its prescription is repeated every 15 minutes, and they are asked to breathe normally.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Information on main outcomes in participant data after de-identification of individuals

When:
The access period starts 6 months after the results are published

To whom:
Researchers working in academic and scientific institutions

Conditions:
The necessary conditions for requesting data include the applicant's profile, the reason for the request, and how to use it.Then the requested items are sent with the opinion of the authors.

Where to obtain:
NiloofarAhmadi97@gmail.com
09151087996 Niloofar SadeghAhmadi

How to obtain:
After the applicant's request, the data will be sent via email within 15 days.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Niloofar SadeghAhmadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 514, North Building, Parsian Tower, Amoozegar 37 Ave, Amoozegar Blvd, Mashhad Town</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9188173282</zip>
        <telephone>+98 51 3864 9954</telephone>
        <email>Niloofarahmadi97@gmail.com</email>
        <affiliation>Gonabad University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Niloofar SadeghAhmadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 514, North Building, Parsian Tower, Amoozegar 37 Ave, Amoozegar Blvd, Mashhad Town</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9188173282</zip>
        <telephone>+98 51 3864 9954</telephone>
        <email>Niloofarahmadi97@gmail.com</email>
        <affiliation>Gonabad University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Women with first and second pregnancy, aged 18-35 years, pregnant with single fetus , having a normal delivery, 38-42 weeks of pregnancy, cephalic presentation, cervical dilatation more than 3 cm.
No history of asthma, sensitivity and allergy according to mother's statements.
Absence of disease and complications of pregnancy and obstetrics (such as: pre-eclampsia - chorioamnionitis - known liver, gallbladder and respiratory disease, decollement and abnormal heartbeat of the fetus at the beginning of the study),
Not having smell problems and allergies to herbal medicines according to the person.
Not having a known anxiety and depression disease according to the person's statements in the medical history and the mother's file.
Not having migraines according to the mother's statements in the medical history.
Not receiving medical painkillers 3 hours before the start of the study.
There is no history of infertility and thyroid disease according to the person's statements in the medical history and the mother's file.
Informed consent of women to participate in the study</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>35 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Mother's non-cooperation in completing the checklist and expressing her pain
Departure from the natural course of labor
Having an emergency caesarean section
Allergic to essential oil
Fetal weight less than 2.5 kg or more than 4 kg</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>First Intervention group: Aromatherapy with lavender essential oil with a concentration of 2% was purchased from Barich Essential Oil Company, which is impregnated with gas to the extent of 0.2 cc and attached to the collar of the participants' clothes, and its prescription is repeated every 15 minutes, and they are asked to breathe normally.</i_keyword>
      <i_keyword>Second Intervention group: Aromatherapy with clove essential oil with a concentration of 2% was purchased from Barich Essential Oil Company, which is impregnated with gas to the extent of 0.2 cc and attached to the collar of the participants' clothes, and its prescription is repeated every 15 minutes, and they are asked to breathe normally.</i_keyword>
      <i_keyword>Control group: In the control group, 0.2 cc of distilled water is impregnated with gas and attached to the collar of the participants' clothes, and its prescription is repeated every 15 minutes, and they are asked to breathe normally.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Labor Pain score. Timepoint: At the beginning of the study,  dilation 4-5 cm , dilatation 8-10 cm. Method of measurement: Visual Analogue Scale (VAS).</prim_outcome>
      <prim_outcome>Anxiety score. Timepoint: At the beginning of the study,  dilation 4-5 cm , dilatation 8-10 cm. Method of measurement: Spielberger anxiety questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Gonabad University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-02-13</approval_date>
        <contact_name>Ethics committee of Gonabad University of Medical Sciences</contact_name>
        <contact_address>No. 514, North Building, Parsian Tower, Amoozegar 37 Ave, Amoozegar Blvd, Mashhad City Mashhad Razavi Khorasan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
